Headache Disorders, Primary
0
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
HM
Hua MedicineChina - Shanghai
2 programsChina Headache and Vertigo Registry StudyN/A1 trial
International Headache Registry StudyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Hua MedicineInternational Headache Registry Study
Hua MedicineChina Headache and Vertigo Registry Study
Clinical Trials (2)
Total enrollment: 210,000 patients across 2 trials
International Headache Registry Study
Start: Jul 2021Est. completion: Dec 2082200,000 patients
N/ARecruiting
China Headache and Vertigo Registry Study
Start: Jun 2017Est. completion: Dec 205010,000 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 210,000 patients
2 companies competing in this space